Repertoire Immune Medicines

Repertoire Immune Medicines is a biotechnology company focused on developing innovative immune therapies to treat cancer, autoimmune disorders, and infectious diseases. They leverage their proprietary DECODE platform to identify and target specific immune receptors, enabling precise and personalized treatments. Founded in 2019 through the merger of Cogen Immune Medicines and Torque Therapeutics, the company has secured significant funding and partnerships to advance its clinical programs. Their approach combines deep immunological insights with cutting-edge technology to address unmet medical needs and improve patient outcomes.

Recent Posts by Repertoire Immune Medicines

1-5 of 5